Request Expert

Expert is currently a litigation consultant, expert witness, and independent consultant for regulatory/due diligence investigations through many years of experience as a DEA diversion/regulatory investigator and supervisor. He has extensive experience with drug compliance and regulation, including conducting and supervising regulatory, civil complaint, criminal drug diversion, administrative, and due diligence investigations. Additionally, Expert assists DEA registered clients in meeting obligations for controlled substance compliance with the Code of Federal Regulations (CFR), as well as and due diligence in dispensing or distribution of controlled substances.

Expert's private sector experience includes two years as the Assistant Director of Compliance for a DEA registered pharmaceutical distributor. This position included directing the day-to-day operation of the Compliance Department, supervising and conducting due diligence investigations of customers as well as monitoring the Suspicious Order Monitoring (SOM) system. Additionally, he investigated independently owned pharmacies for compliance with US Department of Justice/DEA guidelines for dispensing controlled substances. Prior to this, Expert was a Diversion Group Supervisor at the Drug Enforcement Administration from October 2010 - January 2014. Here he was responsible for managing a diversion group of 11 employees including 6 diversion investigators, 4 registration program specialists, and an office assistant within DEA's largest field office. This position entailed the enforcement of the Controlled Substances Act, Code of Federal Regulations, part 1300 to end, as well as implementing DEA policies and procedures. This was accomplished through the direction and oversight of approximately 200 regulatory investigations annually, administrative investigations, due diligence investigations as well as civil complaint and criminal drug diversion cases resulting in successful prosecutions. Expert was also a Senior Diversion Investigator at the Drug Enforcement Administration from April 1987 - October 2010.

RDC 2018-2020 Directed the day-to-day operation of the DEA Compliance Department of a DEA registered distributor, supervised, and conducted due diligence investigations of customers, monitored the Suspicious Order Monitoring (SOM) system, among other responsibilities.

PCG 2014-2018 Conducted investigations of DEA registrants incorporating skills acquired through many years of experience as a DEA regulatory investigator and supervisor in order to fulfill clients' obligations for controlled substance due diligence in dispensing or distribution. Investigated independently owned pharmacies for compliance with US Department of Justice/DEA guidelines for dispensing controlled substances. Provided consultation services for clients such as hospital pharmacies, manufacturers, and wholesalers of controlled substances on DEA regulatory matters.

DEA GS 2010-2014 Group Supervisor responsible for managing a diversion group of 11 employees including 6 diversion investigators, 4 registration program specialists, and an office assistant within DEA's largest field office. This position entailed the enforcement of the Controlled Substances Act, Code of Federal Regulations, part 1300 to end, as well as implementing DEA policies and procedures. This was accomplished through the direction and oversight of approximately 200 regulatory investigations annually, administrative investigations, due diligence investigations as well as civil complaint and criminal drug diversion cases resulting in successful prosecutions. Supervised and provided oversight for the civil investigation of a DEA registered chemical exporter resulting in a civil fine of $420,000.00 which was the second highest civil fine in DEA history for that registrant class. Frequently assumed the position of Acting Diversion Program Manager which provides oversight for the Diversion Program throughout the New York Division. Additional responsibilities included establishing and maintaining liaison and relationships with various federal and state agencies such as the U.S. Attorney's Office, FBI, New York Medical and Pharmacy Boards, and New York Bureau of Narcotic Enforcement.

DEA DI 1987-2010 Senior Diversion Investigator responsible for conducting numerous DEA regulatory investigations, administrative investigations, due diligence investigations as well as civil complaint and criminal drug diversion cases which resulted in successful prosecutions. Civil prosecutions resulted in civil fines amounting to approximately $500,000.00. Criminal investigations resulted in numerous arrests. Administrative actions resulted in several hundred surrenders of DEA registrations and an Order to Show Cause proceeding resulting in revocation of DEA registration. Frequently assumed the position of Acting Group Supervisor for extended time periods up to several months. Established and maintained liaison and relationships with various federal, state, and local agencies, especially the U.S. Attorney's Office, New Haven, Connecticut, and the Connecticut Drug Control Division, Department of Consumer Protection.